SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vista Pharmaceuticals informs about company updates

12 Feb 2018 Evaluate

Vista Pharmaceuticals has informed that the Company had an USFDA Inspection from 1st February to 9th February, 2018. Form 483 has been issued to the company with observations. The Company will respond to the observations in the next 15 working days.

The above information is a part of company’s filings submitted to BSE.

 

Vista Pharma Share Price

7.19 -0.32 (-4.26%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×